Future Diagnostics
Private Company
Funding information not available
Overview
Future Diagnostics is a specialized service provider in the IVD sector, offering comprehensive assay development, optimization, validation, and contract manufacturing services. Its core value proposition is accelerating time-to-market for clients by integrating regulatory compliance (ISO 13485, FDA, IVDR) from the start and utilizing its proprietary micro-SCY™ platform for superior antibody screening. The company serves a global clientele ranging from large multinationals to small biotechs, positioning itself as a technical and regulatory partner rather than just a vendor.
Technology Platform
Proprietary micro-SCY™ platform for high-throughput antibody screening and characterization, enabling faster identification of optimal antibody-antigen pairs for robust immunoassay development.
Opportunities
Risk Factors
Competitive Landscape
Competes with large, full-service CROs (e.g., LabCorp, IQVIA) and specialized IVD CDMOs. Differentiation is achieved through deep, niche expertise in immunoassays, a proprietary screening platform, and integrated regulatory strategy from project inception.